32 results on '"Aguiar CL"'
Search Results
2. Removal of Pigments from Sugarcane Cells by Adsorbent Chromatographic Column
- Author
-
GR, Manarim, primary and Aguiar CL, De, additional
- Published
- 2016
- Full Text
- View/download PDF
3. Própolis produzida no sul do Brasil, Argentina e Uruguai: evidências fitoquímicas de sua origem vegetal
- Author
-
Park Yong Kun, Alencar Severino Matias, Scamparini Adilma Regina Pippa, and Aguiar Claudio Lima
- Subjects
própolis ,origem botânica ,Populus alba ,compostos fenólicos ,Agriculture ,Agriculture (General) ,S1-972 - Abstract
A própolis é uma substância resinosa coletada pelas abelhas de diversas partes da planta. Sua composição depende da época, vegetação e área de coleta. Própolis produzida por abelhas Apis mellifera africanizada do sul do Brasil, Argentina e Uruguai foram investigadas por meio de técnicas cromatográficas. De acordo com os resultados obtidos por CCDAE-FR, CLAE-FR e CG-EM, as própolis do sul do Brasil foram classificadas em 5 grupos distintos. Com base nas evidências fitoquímicas, Populus alba foi identificada como a principal fonte da própolis do grupo 3 do sul do Brasil, Argentina e Uruguai.
- Published
- 2002
4. Assessing Clinical Improvement of Infants Hospitalized for Respiratory Syncytial Virus-Related Critical Illness.
- Author
-
Leland SB, Zambrano LD, Staffa SJ, McNamara ER, Newhams MM, Halasa N, Amarin JZ, Stewart LS, Shein SL, Carroll CL, Fitzgerald JC, Michaels MG, Bline K, Cullimore ML, Loftis L, Montgomery VL, Jeyapalan AS, Pannaraj PS, Schwarz AJ, Cvijanovich NZ, Zinter MS, Maddux AB, Bembea MM, Irby K, Zerr DM, Kuebler JD, Babbitt CJ, Gaspers MG, Nofziger RA, Kong M, Coates BM, Schuster JE, Gertz SJ, Mack EH, White BR, Harvey H, Hobbs CV, Dapul H, Butler AD, Bradford TT, Rowan CM, Wellnitz K, Staat MA, Aguiar CL, Hymes SR, Campbell AP, and Randolph AG
- Abstract
Background: Pediatric respiratory syncytial virus (RSV)-related acute lower respiratory tract infection (LRTI) commonly requires hospitalization. The Clinical Progression Scale Pediatrics (CPS-Ped) measures level of respiratory support and degree of hypoxia across a range of disease severity, but it has not been applied in infants hospitalized with severe RSV-LRTI., Methods: We analyzed data from a prospective surveillance registry of infants hospitalized for RSV-related complications across 39 U.S. PICUs from October through December 2022. We assigned CPS-Ped (0=discharged home at respiratory baseline to 8=death) at admission, days 2-7,10, and 14. We identified predictors of clinical improvement (CPS-Ped≤2 or 3-point decrease) by day 7 using multivariable log-binomial regression models and estimated the sample size (80% power) to detect 15% between-group clinical improvement with CPS-Ped versus hospital length of stay (LOS)., Results: Of 585 hospitalized infants, 138 (23.6%) received invasive mechanical ventilation (IMV). Of the 49 (8.4%) infants whose CPS-Ped score worsened by 2 points after admission, one died. Failure to clinically improve by day 7 occurred in 205 (35%) infants and was associated with age <3 months, prematurity, underlying respiratory condition, and IMV in the first 24 hours in the multivariable analysis. The estimated sample size per arm required for detecting a 15% clinical improvement in a potential study was 584 using CPS-Ped clinical improvement versus 2,031 for hospital LOS., Conclusions: CPS-Ped can be used to capture a range of disease severity and track clinical improvement in infants who develop RSV-related critical illness and could be useful for evaluating therapeutic interventions for RSV., (© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2025
- Full Text
- View/download PDF
5. A mouse model of sleep disorders in Parkinson's disease showing distinct effects of dopamine D2-like receptor activation.
- Author
-
Medeiros DC, Plewnia C, Mendes RV, Pisanò CA, Boi L, Moraes MFD, Aguiar CL, and Fisone G
- Subjects
- Humans, Female, Mice, Animals, Dopamine, Pramipexole pharmacology, Pramipexole therapeutic use, Quality of Life, Sleep, Disease Models, Animal, Parkinson Disease drug therapy, Sleep Wake Disorders drug therapy, Sleep Wake Disorders etiology
- Abstract
Excessive daytime sleepiness (EDS) and sleep fragmentation are often observed in Parkinson's disease (PD) patients and are poorly understood despite their considerable impact on quality of life. We examined the ability of a neurotoxin-based mouse model of PD to reproduce these disorders and tested the potential counteracting effects of dopamine replacement therapy. Experiments were conducted in female mice with a unilateral 6-hydroxydopamine lesion of the medial forebrain bundle, leading to the loss of dopamine neurons projecting to the dorsal and ventral striatum. Sham-operated mice were used as control. Electroencephalographic and electromyographic recording was used to identify and quantify awaken, rapid eye movement (REM) and non-REM (NREM) sleep states. PD mice displayed enhanced NREM sleep and reduced wakefulness during the active period of the 24-hour circadian cycle, indicative of EDS. In addition, they also showed fragmentation of NREM sleep and increased slow-wave activity, a marker of sleep pressure. Electroencephalographic analysis of the PD model also revealed decreased density and increased length of burst-like thalamocortical oscillations (spindles). Treatment of PD mice with the dopamine receptor agonist, pramipexole, but not with L-DOPA, counteracted EDS by reducing the number, but not the length, of NREM sleep episodes during the first half of the active period. The present model recapitulates some prominent PD-related anomalies affecting sleep macro- and micro-structure. Based on the pharmacological profile of pramipexole these results also indicate the involvement of impaired dopamine D2/D3 receptor transmission in EDS., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interest., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
6. Curved OLED-based NLOS optical camera communications links.
- Author
-
Teli SR, Matus V, Aguiar CL, Perez-Jimenez R, Ghassemlooy Z, and Zvanovec S
- Abstract
In this paper, for the first time, to the best of our knowledge, we experimentally demonstrate the use of a curved organic light emitting diode (OLED) as a transmitter (Tx) in the non-line-of-sight (NLOS) optical camera communication (OCC) link for an indoor environment using a camera as a receiver. The proposed NLOS-OCC scheme is evaluated for the signal-to-noise ratio (SNR) and the reception success rates R
r s under key photographic and communication parameters, including exposure times te x p and gain values Gv , as well as the transmission frequency fs and the distance L . The SNR analysis is performed using a binary classification procedure based on a Gaussian mixture model for the first time, to the best of our knowledge, for OLED-based NLOS-OCC links. We also derive and demonstrate that the effect of Gv on the SNR with respect to L is minimal based on the pixel illumination model. The initial analysis suggests that, for a wall reflector-based NLOS-OCC link that is 2 m long, the SNR and Rr s increase by 1 dB and 4% (83-87%) for fs of 600 Hz, with an increase in te x p of 1000-1500 µs and Gv of 25-45 dB.- Published
- 2023
- Full Text
- View/download PDF
7. Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak.
- Author
-
Halasa N, Zambrano LD, Amarin JZ, Stewart LS, Newhams MM, Levy ER, Shein SL, Carroll CL, Fitzgerald JC, Michaels MG, Bline K, Cullimore ML, Loftis L, Montgomery VL, Jeyapalan AS, Pannaraj PS, Schwarz AJ, Cvijanovich NZ, Zinter MS, Maddux AB, Bembea MM, Irby K, Zerr DM, Kuebler JD, Babbitt CJ, Gaspers MG, Nofziger RA, Kong M, Coates BM, Schuster JE, Gertz SJ, Mack EH, White BR, Harvey H, Hobbs CV, Dapul H, Butler AD, Bradford TT, Rowan CM, Wellnitz K, Staat MA, Aguiar CL, Hymes SR, Randolph AG, and Campbell AP
- Subjects
- Child, Infant, Humans, Male, Female, Prospective Studies, Seasons, Cross-Sectional Studies, Hospitalization, Respiratory Syncytial Viruses, Intensive Care Units, Respiratory Syncytial Virus Infections epidemiology, Respiratory Syncytial Virus Infections therapy, Respiratory Tract Infections
- Abstract
Importance: Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections (LRTIs) and infant hospitalization worldwide., Objective: To evaluate the characteristics and outcomes of RSV-related critical illness in US infants during peak 2022 RSV transmission., Design, Setting, and Participants: This cross-sectional study used a public health prospective surveillance registry in 39 pediatric hospitals across 27 US states. Participants were infants admitted for 24 or more hours between October 17 and December 16, 2022, to a unit providing intensive care due to laboratory-confirmed RSV infection., Exposure: Respiratory syncytial virus., Main Outcomes and Measures: Data were captured on demographics, clinical characteristics, signs and symptoms, laboratory values, severity measures, and clinical outcomes, including receipt of noninvasive respiratory support, invasive mechanical ventilation, vasopressors or extracorporeal membrane oxygenation, and death. Mixed-effects multivariable log-binomial regression models were used to assess associations between intubation status and demographic factors, gestational age, and underlying conditions, including hospital as a random effect to account for between-site heterogeneity., Results: The first 15 to 20 consecutive eligible infants from each site were included for a target sample size of 600. Among the 600 infants, the median (IQR) age was 2.6 (1.4-6.0) months; 361 (60.2%) were male, 169 (28.9%) were born prematurely, and 487 (81.2%) had no underlying medical conditions. Primary reasons for admission included LRTI (594 infants [99.0%]) and apnea or bradycardia (77 infants [12.8%]). Overall, 143 infants (23.8%) received invasive mechanical ventilation (median [IQR], 6.0 [4.0-10.0] days). The highest level of respiratory support for nonintubated infants was high-flow nasal cannula (243 infants [40.5%]), followed by bilevel positive airway pressure (150 infants [25.0%]) and continuous positive airway pressure (52 infants [8.7%]). Infants younger than 3 months, those born prematurely (gestational age <37 weeks), or those publicly insured were at higher risk for intubation. Four infants (0.7%) received extracorporeal membrane oxygenation, and 2 died. The median (IQR) length of hospitalization for survivors was 5 (4-10) days., Conclusions and Relevance: In this cross-sectional study, most US infants who required intensive care for RSV LRTIs were young, healthy, and born at term. These findings highlight the need for RSV preventive interventions targeting all infants to reduce the burden of severe RSV illness.
- Published
- 2023
- Full Text
- View/download PDF
8. Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children.
- Author
-
Chang JC, Young CC, Muscal E, Sexson Tejtel SK, Newhams MM, Kucukak S, Crandall H, Maddux AB, Rowan CM, Halasa NB, Harvey HA, Hobbs CV, Hall MW, Kong M, Aguiar CL, Schuster JE, Fitzgerald JC, Singh AR, Wellnitz K, Nofziger RA, Cvijanovich NZ, Mack EH, Schwarz AJ, Heidemann SM, Newburger JW, Zambrano LD, Campbell AP, Patel MM, Randolph AG, and Son MBF
- Subjects
- C-Reactive Protein, Retrospective Studies, Glucocorticoids therapeutic use, Systemic Inflammatory Response Syndrome, Child, Immunoglobulins, Intravenous therapeutic use, Ventricular Function, Left, Humans, COVID-19 complications, Stroke Volume, Connective Tissue Diseases, Interleukin 1 Receptor Antagonist Protein therapeutic use
- Abstract
Objective: Evidence regarding effectiveness of interleukin-1 receptor antagonism in multisystem inflammatory syndrome in children (MIS-C) is lacking. We characterized variation in initial treatment with anakinra and evaluated cardiovascular outcomes associated with adding anakinra to standard initial therapy., Methods: We conducted a retrospective cohort study of MIS-C cases in a US surveillance registry from November 2020 to December 2021. Day 0 was the first calendar day of immunomodulatory treatment. Factors associated with initial anakinra use (days 0-1) were identified. We compared cases in patients ages 2-20 years receiving intravenous immunoglobulin (IVIG) and glucocorticoids versus anakinra plus IVIG and/or glucocorticoids on days 0-1, using inverse probability weighting to balance disease severity. Primary outcomes were vasopressor requirement on day 3 and impaired left ventricular ejection fraction on days 3-4. The secondary outcome was 50% reduction in C-reactive protein on day 3., Results: Among 1,516 MIS-C cases at 44 sites, 193 (13%) patients received anakinra alone or with other immunomodulators as initial treatment (range 0-74% by site). Site accounted for 59% of residual variance in anakinra use. After balancing disease severity, initial treatment with anakinra plus IVIG and/or glucocorticoids (n = 121) versus IVIG plus glucocorticoids (n = 389) was not associated with significant differences in vasopressor requirement (25.6% versus 20.1%, respectively; risk ratio [RR] 1.27 [95% confidence interval (95% CI) 0.88-1.84]), ventricular dysfunction (33.7% versus 25.7%, respectively; RR 1.31 [95% CI 0.98-1.75]), or C-reactive protein reduction., Conclusion: We identified substantial variation in initial anakinra use in a real-world population of children with MIS-C, but no average short-term improvement in cardiovascular outcomes associated with early addition of anakinra to IVIG and/or glucocorticoids compared to IVIG and glucocorticoids alone., (© 2023 American College of Rheumatology.)
- Published
- 2023
- Full Text
- View/download PDF
9. Bell's palsy with facial bone involvement: A rare presentation of chronic nonbacterial osteomyelitis with literature review.
- Author
-
Ailumerab HA and Aguiar CL
- Subjects
- Humans, Female, Child, Clindamycin therapeutic use, Pain, Facial Bones pathology, Bell Palsy diagnosis, Facial Paralysis, Osteomyelitis complications, Osteomyelitis diagnosis, Osteomyelitis drug therapy
- Abstract
Chronic nonbacterial osteomyelitis (CNO) is a chronic, sterile, inflammatory disease. It primarily presents with nonspecific bone pain and swelling but ultimately can cause bone destruction and deformities, if left untreated. The involvement of the cranial bones (apart from the mandible) is rare in CNO. In this report, we present a rare case of CNO affecting facial and cranial bones presenting as facial palsy with a review of the literature about similar affection. A 10-year-old, previously healthy female was initially evaluated for swelling of the left side of her face with slight tenderness on palpation, but no fever. Her complete blood count was unremarkable, her inflammatory markers were elevated (C-reactive protein 7.5 mg/dl and erythrocyte sedimentation rate 104 mm/h), and CT of facial and skull bones and MRI of brain showed a destructive osseous process involving the left maxillary, zygomatic, sphenoid bones and the clivus. Bone biopsy of the left maxilla showed fibrous dysplasia with abscess formation, most consistent with an infectious aetiology (acute osteomyelitis). She was started on oral clindamycin for a 3-month course. The facial swelling improved after starting clindamycin, but on her sixth week of treatment, she developed right-sided Bell's palsy. An MRI of the brain showed hyperenhancement of the right seventh cranial nerve. A month later, she was evaluated for right wrist and knee swelling, pain, and limitation of movement. Skeletal survey and MRI showed multifocal lesions with mixed sclerosis and lucency. Her inflammatory markers continued to be elevated. Another bone biopsy of the right radius showed similar findings of destruction with no evidence of malignancy. She was ultimately diagnosed with CNO. She was started on nonsteroidal anti-inflammatory drugs with gastric protection and regular follow-up. Over more than a year of follow-up, the patient's inflammatory markers remain normal, and joint swelling/limitation has remained in remission. We found five additional cases in the literature that presented with a similar presentation. To our knowledge, our patient is the first reported case in the USA involving the cranial/facial bones apart from the mandible presenting with facial palsy. The affection of the facial bones (apart from the mandible) in CNO is very rare, but the awareness of such a presentation by the clinician is an important aspect of reaching the diagnosis., (© Japan College of Rheumatology 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
10. Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020.
- Author
-
LaRovere KL, Poussaint TY, Young CC, Newhams MM, Kucukak S, Irby K, Kong M, Schwartz SP, Walker TC, Bembea MM, Wellnitz K, Havlin KM, Cvijanovich NZ, Hall MW, Fitzgerald JC, Schuster JE, Hobbs CV, Halasa NB, Singh AR, Mack EH, Bradford TT, Gertz SJ, Schwarz AJ, Typpo KV, Loftis LL, Giuliano JS Jr, Horwitz SM, Biagas KV, Clouser KN, Rowan CM, Maddux AB, Soma VL, Babbitt CJ, Aguiar CL, Kolmar AR, Heidemann SM, Harvey H, Zambrano LD, Campbell AP, and Randolph AG
- Subjects
- Male, Systemic Inflammatory Response Syndrome, Female, Humans, COVID-19 Vaccines, Adolescent, SARS-CoV-2, Pandemics, Child, Inpatients, United States epidemiology, Guillain-Barre Syndrome epidemiology, COVID-19 complications, COVID-19 epidemiology, Nervous System Diseases epidemiology, Nervous System Diseases etiology, Stroke epidemiology
- Abstract
Importance: In 2020 during the COVID-19 pandemic, neurologic involvement was common in children and adolescents hospitalized in the United States for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related complications., Objective: To provide an update on the spectrum of SARS-CoV-2-related neurologic involvement among children and adolescents in 2021., Design, Setting, and Participants: Case series investigation of patients reported to public health surveillance hospitalized with SARS-CoV-2-related illness between December 15, 2020, and December 31, 2021, in 55 US hospitals in 31 states with follow-up at hospital discharge. A total of 2253 patients were enrolled during the investigation period. Patients suspected of having multisystem inflammatory syndrome in children (MIS-C) who did not meet criteria (n = 85) were excluded. Patients (<21 years) with positive SARS-CoV-2 test results (reverse transcriptase-polymerase chain reaction and/or antibody) meeting criteria for MIS-C or acute COVID-19 were included in the analysis., Exposure: SARS-CoV-2 infection., Main Outcomes and Measures: Patients with neurologic involvement had acute neurologic signs, symptoms, or diseases on presentation or during hospitalization. Life-threatening neurologic involvement was adjudicated by experts based on clinical and/or neuroradiological features. Type and severity of neurologic involvement, laboratory and imaging data, vaccination status, and hospital discharge outcomes (death or survival with new neurologic deficits)., Results: Of 2168 patients included (58% male; median age, 10.3 years), 1435 (66%) met criteria for MIS-C, and 476 (22%) had documented neurologic involvement. Patients with neurologic involvement vs without were older (median age, 12 vs 10 years) and more frequently had underlying neurologic disorders (107 of 476 [22%] vs 240 of 1692 [14%]). Among those with neurologic involvement, 42 (9%) developed acute SARS-CoV-2-related life-threatening conditions, including central nervous system infection/demyelination (n = 23; 15 with possible/confirmed encephalitis, 6 meningitis, 1 transverse myelitis, 1 nonhemorrhagic leukoencephalopathy), stroke (n = 11), severe encephalopathy (n = 5), acute fulminant cerebral edema (n = 2), and Guillain-Barré syndrome (n = 1). Ten of 42 (24%) survived with new neurologic deficits at discharge and 8 (19%) died. Among patients with life-threatening neurologic conditions, 15 of 16 vaccine-eligible patients (94%) were unvaccinated., Conclusions and Relevance: SARS-CoV-2-related neurologic involvement persisted in US children and adolescents hospitalized for COVID-19 or MIS-C in 2021 and was again mostly transient. Central nervous system infection/demyelination accounted for a higher proportion of life-threatening conditions, and most vaccine-eligible patients were unvaccinated. COVID-19 vaccination may prevent some SARS-CoV-2-related neurologic complications and merits further study.
- Published
- 2023
- Full Text
- View/download PDF
11. Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series.
- Author
-
Toplak N, Pimpale Chavan P, Rosina S, Dallos T, Rotem Semo O, Aguiar CL, Khubchandani R, Ravelli A, and Patwardhan A
- Abstract
Juvenile dermatomyositis (JDM) has a wide spectrum of clinical presentations. In the last decade, several myositis-specific antibodies have been identified in patients with JDM and connected with specific organ involvement or specific clinical picture. It has been published that the presence of anti-NXP2 autoantibodies presents a risk for calcinosis in patients with JDM. We aimed to investigate the prevalence of calcinosis and response to the treatment in JDM patients with anti-NXP2. In a retrospective, multinational, multicenter study, data on 26 JDM (19 F, 7 M) patients with positive anti-NXP2 were collected. The mean age at disease presentation was 6.5 years (SD 3.7), the median diagnosis delay was 4 months (range 0.5-27 months). Patients were divided into two groups (A and B) based on the presence of calcinosis, which occurred in 42% of anti-NXP2 positive JDM patients (group A). Four patients already had calcinosis at presentation, one developed calcinosis after 4 months, and 6 developed calcinosis later in the disease course (median 2 years, range 0.8-7.8). The differences in laboratory results were not statistically significant between the groups. The mean age at disease presentation (5.2/7.5 years) trended toward being younger in group A. Children with calcinosis were treated with several combinations of drugs. In four cases, rituximab and, in one case, anti-TNF alpha agents were used successfully. Disease outcome (by evaluation of the treating physician) was excellent in four, good in two, stable in two, and poor in three patients. None of the patients from group B had a poor disease outcome. In conclusion, JDM patients with anti-NXP2 are prone to develop calcinosis, especially if they present with the disease early, before 5 years of age. The development of calcinosis is associated with worse disease outcomes. The combination of several immunomodulatory drugs and biologic drugs can stop calcinosis progression; however, there are no evidence-based therapies for treating calcinosis in JDM patients., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Toplak, Pimpale Chavan, Rosina, Dallos, Rotem Semo, Aguiar, Khubchandani, Ravelli and Patwardhan.)
- Published
- 2022
- Full Text
- View/download PDF
12. Evaluation of Techniques for Intensifying the Process of the Alcoholic Extraction of Coffee Ground Oil Using Ultrasound and a Pressurized Solvent.
- Author
-
Toda TA, Santana AJM, Ferreira JA, Pallone EMJA, Aguiar CL, and Rodrigues CEDC
- Abstract
Ultrasound-assisted extraction (UAE) and pressurized liquid extraction (PLE) techniques were evaluated and compared with conventional extraction for obtaining spent coffee ground oil (SCGO). The use of absolute ethanol (ET0) and hydrated ethanol (ET6) as solvents, two levels of SCG mass ratio:solvent, 1:4 (U4) and 1:15 (U15), and ultrasound powers of 0, 200, 400, and 600 W were tested. ET0 and U15 resulted in higher extraction yields of SCGO (Y
SCGO , 82%). A positive effect of sonication on YSCGO was observed only for condition U4. UAE resulted in defatted solids (DS) with higher apparent density values, corroborating the increase in the amount of smaller diameter particles due to sonication. The micrographs showed changes in the surfaces of the solids from the UAE and PLE, although the crystalline structures of the DS were not altered. UAE and PLE, compared to conventional extraction, did not allow significant gains in terms of YSCGO and, consequently, in the number of contact stages in an extractor configured in cross-currents.- Published
- 2022
- Full Text
- View/download PDF
13. Juvenile dermatomyositis resembling late-stage Degos disease with gastrointestinal perforations successfully treated with combination of cyclophosphamide and rituximab: case-based review.
- Author
-
Day W, Gabriel C, Kelly RE Jr, Magro CM, Williams JV, Werner A, Gifford L, Lapsia SP, and Aguiar CL
- Subjects
- Child, Cyclophosphamide therapeutic use, Dermatomyositis complications, Dermatomyositis drug therapy, Diagnosis, Differential, Digestive System Surgical Procedures, Duodenal Diseases diagnosis, Duodenal Diseases therapy, Esophageal Perforation diagnosis, Esophageal Perforation therapy, Female, Humans, Intestinal Perforation etiology, Intestinal Perforation therapy, Jejunal Diseases diagnosis, Jejunal Diseases therapy, Rituximab therapeutic use, Antirheumatic Agents therapeutic use, Dermatomyositis diagnosis, Intestinal Perforation diagnosis, Malignant Atrophic Papulosis diagnosis
- Abstract
Dermatomyositis (DM) is a multi-system disease that results in chronic inflammation principally of the skin and striated muscle. Small blood vessel injury in the GI tract has been described in dermatomyositis, manifesting as bleeding, ulceration, pneumatosis intestinalis, and ultimately perforation. Recent histopathological studies have shown deposits in the capillaries of the skin, gastrointestinal tract, and brain of patients with dermatomyositis similar to that found in patients with Degos disease, suggesting these disease processes are closely related or represent varying degrees of severity on the same pathologic spectrum. We report a case of juvenile dermatomyositis (JDM) resembling late-stage Degos disease with gastrointestinal perforations successfully treated with combination rituximab and cyclophosphamide therapy. We systematically reviewed the literature detailing the medical and surgical treatments for gastrointestinal perforation in dermatomyositis, Degos-like dermatomyositis, and Degos disease. In addition to our case, as of October 2019, we identified 36 cases describing gastrointestinal perforation in patients with underlying dermatomyositis, 5 cases of Degos-like dermatomyositis and 17 cases of idiopathic Degos disease. Corticosteroid therapy was used widely for dermatomyositis and Degos-like dermatomyositis, while antiplatelet and anticoagulant medications were chiefly used for patients with idiopathic Degos disease. However, there were no cases that detailed the successful treatment of dermatomyositis or Degos disease with gastrointestinal perforation with rituximab alone or combined with cyclophosphamide. We report that rituximab, in combination with cyclophosphamide, can be used as a novel adjunctive therapy to successfully treat dermatomyositis with Degos-like gastrointestinal perforation.
- Published
- 2020
- Full Text
- View/download PDF
14. Structures related to resprouting potential of two Myrtaceae species from Cerrado: morpho-anatomical and chemical studies.
- Author
-
Silva GSD, Ferraro A, Ogando FIB, Aguiar CL, and Appezzato-DA-Glória B
- Subjects
- Brazil, Fires, Myrtaceae chemistry, Myrtaceae classification, Plant Roots chemistry, Germination physiology, Myrtaceae growth & development, Plant Roots physiology
- Abstract
Resprouting is a functional trait in species which occur in fire-prone ecosystems. These plants can resprout from aerial buds and by recruiting belowground bud bank using carbohydrates allocated in roots as resource. In this study, we present morpho-anatomical features and chemical composition related to the resprouting potential of two species of Eugenia L. in an area of the Cerrado (Brazilian savanna) under regeneration, after the clear-cutting of Pinus sp. with the later burning of pine needles layer. We used standard histological techniques for belowground organs analysis and aerial buds protection degree. Belowground buds in layer from soil surface down to 10 depth were counted and the chemical analyses were performed on roots. In all aerial buds, there were relevant protection traits. The belowground organ is a sobole and the number of buds in its upper portion varied from 24 to 517 between individuals of both species. Phenolic compounds, flavonoids, starch and other carbohydrates were detected in roots. The protection of aerial buds, the large number of belowground buds and the storing and protective compounds may have favored the resprouting of the species in the area.
- Published
- 2020
- Full Text
- View/download PDF
15. Removal of phenolic, turbidity and color in sugarcane juice by electrocoagulation as a sulfur-free process.
- Author
-
Ogando FIB, Aguiar CL, Viotto JVN, Heredia FJ, and Hernanz D
- Subjects
- Brazil, Color, Food Analysis, Fruit and Vegetable Juices, Kinetics, Electrocoagulation methods, Phenols chemistry, Saccharum chemistry, Sulfur chemistry
- Abstract
This work analyzed the use of electrocoagulation as substitute for sugarcane clarification process using sulfitation. It was evaluated technological parameters (Icumsa color and turbidity), phenolic compounds content and CIELAB color parameters. Four kinetics of reduction color from sugarcane juice were carried out. The essays were divided according to the voltage applied: 35, 45, 55 and 65 V (also based on previous tests). Higher voltage treatments achieved greater reduction of Icumsa color, turbidity and total phenolic compounds. However, none of treatments impacted simple phenolic content analyzed in this work. Tristimulus analysis presented some pattern that went beyond technological analysis, including that 65 V essay changed the pigmentation of sugarcane juice and had an early stabilization on chroma. This kind of results could be useful for industry, once they could correlate quality with different color parameters and finally improve the clarification in general with finer settings of technique according to different situations., (Copyright © 2019 Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
16. Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity.
- Author
-
Ruff WE, Dehner C, Kim WJ, Pagovich O, Aguiar CL, Yu AT, Roth AS, Vieira SM, Kriegel C, Adeniyi O, Mulla MJ, Abrahams VM, Kwok WW, Nussinov R, Erkan D, Goodman AL, and Kriegel MA
- Subjects
- Adult, Aged, Animals, Antiphospholipid Syndrome pathology, Autoantibodies blood, Autoantibodies immunology, Female, Gastrointestinal Tract microbiology, Humans, Immunoglobulin G blood, Male, Mice, Middle Aged, Models, Animal, Young Adult, beta 2-Glycoprotein I immunology, Antibodies, Bacterial immunology, Antigens, Bacterial immunology, Autoimmunity, B-Lymphocytes immunology, Clostridiales immunology, Cross Reactions, T-Lymphocytes immunology
- Abstract
Given the immense antigenic load present in the microbiome, we hypothesized that microbiota mimotopes can be a persistent trigger in human autoimmunity via cross-reactivity. Using antiphospholipid syndrome (APS) as a model, we demonstrate cross-reactivity between non-orthologous mimotopes expressed by a common human gut commensal, Roseburia intestinalis (R. int), and T and B cell autoepitopes in the APS autoantigen β
2 -glycoprotein I (β2 GPI). Autoantigen-reactive CD4+ memory T cell clones and an APS-derived, pathogenic monoclonal antibody cross-reacted with R. int mimotopes. Core-sequence-dependent anti-R. int mimotope IgG titers were significantly elevated in APS patients and correlated with anti-β2 GPI IgG autoantibodies. R. int immunization of mice induced β2 GPI-specific lymphocytes and autoantibodies. Oral gavage of susceptible mice with R. int induced anti-human β2 GPI autoantibodies and autoimmune pathologies. Together, these data support a role for non-orthologous commensal-host cross-reactivity in the development and persistence of autoimmunity in APS, which may apply more broadly to human autoimmune disease., (Copyright © 2019 Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
17. Rituximab use in pediatric lupus anticoagulant hypoprothrombinemia syndrome - report of three cases and review of the literature.
- Author
-
Cetin Gedik K, Siddique S, and Aguiar CL
- Subjects
- Adolescent, Child, Female, Humans, Hypoprothrombinemias blood, Male, Partial Thromboplastin Time, Prothrombin Time, beta 2-Glycoprotein I immunology, Hypoprothrombinemias drug therapy, Lupus Coagulation Inhibitor blood, Rituximab therapeutic use
- Abstract
Lupus anticoagulant hypoprothrombinemia syndrome (LA-HPS) is a rare condition that may predispose both to thrombosis and bleeding due to positive lupus anticoagulant (LA) and factor II (FII) deficiency. It can be seen in association with infections or systemic lupus erythematosus (SLE) and may require glucocorticoids (GCs) and/or immunosuppressive medications. Pediatric LA-HPS cases in the literature and three cases that received only rituximab (RTX) for LA-HPS (in addition to GCs) at two institutions between January 2010 and June 2017 were analyzed descriptively. Pediatric LA-HPS cases (≤18 years) with bleeding or thrombotic events were included. Information obtained included demographics, presenting symptoms, diagnoses, treatments, pre-/post-treatment prothrombin time (PT)/partial thromboplastin time (PTT)/LA/FII levels, and outcomes. In addition to three LA-HPS cases identified at our institutions, as of June 2017, 37 articles reported 54 pediatric LA-HPS cases (mean age: 8 years (0.9-17 years); female/male: (2:1); viral illness 27 (50%), SLE 20 (37%), and other six (11%)). All cases had a positive LA and FII deficiency (range: 0%-40%). All cases presented with bleeding diathesis and were treated with various regimens, but there was no reported use of RTX. The purpose of this report is to describe the novel use of RTX as a steroid-sparing agent in three pediatric SLE cases and to systematically review the literature on pediatric cases of LA-HPS.
- Published
- 2018
- Full Text
- View/download PDF
18. Spittlebugs produce foam as a thermoregulatory adaptation.
- Author
-
Tonelli M, Gomes G, Silva WD, Magri NTC, Vieira DM, Aguiar CL, and Bento JMS
- Subjects
- Animals, Temperature, Adaptation, Physiological, Body Temperature Regulation, Ecosystem, Foam Cells physiology, Hemiptera physiology, Nymph physiology
- Abstract
Insects have evolved multiple mechanisms to adapt to variations in environmental temperatures, including postural control of solar input, variations in diurnal activity, external morphological structures and selecting/generating microhabitats. Foam produced by Mahanarva fimbriolata nymphs (also known as root spittlebugs) was found to aid in creating a constant thermal microhabitat despite environmental temperature fluctuations. The temperature within the foam was found to be similar to that of soil during the day and remained constant despite fluctuating external temperatures. In chemically analysing the composition of the foam, palmitic and stearic acids, carbohydrates and proteins were detected. These substances have previously been shown to act as a surfactant to stabilize and modulate foams. Since the immature ancestor of the spittlebug developed below ground, it is speculated that the foam may function as an 'extension' of the soil and, thus, may have enabled the spittlebug to emerge from the soil and adopt an epigean lifestyle.
- Published
- 2018
- Full Text
- View/download PDF
19. Metabolomics and Agriculture: What Can Be Done?
- Author
-
do Prado RM, Porto C, Nunes E, de Aguiar CL, and Pilau EJ
- Abstract
The importance of Brazil as a producer and exporter of food and feed will continuously increase. Despite the recent economic and political problems in Brazil, the scientific field is expanding. Cutting-edge technology has only recently become available in the country, and we can now also join efforts with the global community to tackle global challenges. Using metabolomics based on mass spectrometry approaches to understand system-wide metabolism and metabolic pathways can have a significant impact in the society. With the recent development of a platform for organization and sharing of tandem mass spectrometry data, the global community can now work with complex biological samples. In this Perspective, we aim to describe how challenges and problems in global and local agriculture can be addressed using metabolomics based on mass spectrometry strategies., Competing Interests: Conflict of Interest Disclosures: R.M.D.P. has nothing to disclose. C.P. has nothing to disclose. E.O. has nothing to disclose. C.L.D.A. has nothing to disclose. E.J.P. has nothing to disclose. Conflict of Interest Disclosures: R.M.D.P. has nothing to disclose. C.P. has nothing to disclose. E.O. has nothing to disclose. C.L.D.A. has nothing to disclose. E.J.P. has nothing to disclose.
- Published
- 2018
- Full Text
- View/download PDF
20. Criegee mechanism as a safe pathway of color reduction in sugarcane juice by ozonation.
- Author
-
de Souza Sartori JA, Angolini CF, Eberlin MN, and Aguiar CL
- Subjects
- Beverages, Color, Alkenes chemistry, Ozone chemistry, Saccharum chemistry
- Abstract
The production of crystal sugar is based on sugarcane juice clarification through sulphitation, that is, heat treatment with sulfur dioxide. The use of ozonation as an alternative to sulphitation aims to eliminate the disadvantageous presence of residual sulfite in crystal sugar. Both treatments are used to reduce color of sugarcane juice. The objective of this work was to evaluate two process parameters (temperature and pH) to reduce gallic acid, a low molecular weight pigment (MW 170gmol
-1 ) widely found in sugarcane. Gallic acid was used as a model compound in sucrose solutions. The results showed that degradation of gallic acid was favored from pH 7.0 to 7.82 and temperature values between 50 and 70°C. The reaction mechanism was proposed for gallic acid degradation by ozone based on Criegee mechanism. Ozonation was an efficient method to reduce the potential low molecular weight pigment present in the sugarcane., (Copyright © 2017 Elsevier Ltd. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
21. Physiological development of cagaita (Eugenia dysenterica).
- Author
-
da Silva MMM, da Silva EP, da Silva FA, Ogando FIB, de Aguiar CL, and Damiani C
- Subjects
- Carotenoids analysis, Chlorophyll analysis, Fruit growth & development, Fruit metabolism, Sucrose analysis, Syzygium, Ethylenes metabolism, Eugenia physiology, Fruit chemistry
- Abstract
It was evaluated the physiological aspects of the cagaita (Eugenia dysenterica) development, from anthesis to ripening. The fruits have been subjected to physical and chemical analysis during the fruit life cycle. The total fruit development comprised 37days. There was a steady increase in the total mass of the fruits and significant increase in transverse and longitudinal diameter, adjusting the double sigmoidal behavior in response to changes in the time. From the 23rd DAA, it was observed the beginning of loss of firmness, increase in total and soluble pectin content and a decrease in starch content. It occurred degradation of total chlorophyll and unmasking of carotenoids from 31st days after anthesis. A decrease in pH and, therefore, increase in acidity, low soluble solids content. The sucrose content was extremely low during the cycle. At the end of development, the respiratory and ethylene production peak was observed, suggesting climacteric behavior., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
22. Anaphylaxis to anakinra in a pediatric patient with systemic juvenile idiopathic arthritis successfully treated with canakinumab: a case-based review.
- Author
-
Aguiar CL, Pan N, Adams A, Barinstein L, and Lehman TJ
- Subjects
- Antibodies, Monoclonal, Humanized, Child, Preschool, Eosinophilia etiology, Humans, Ileostomy, Interleukin-1beta antagonists & inhibitors, Male, Steroids therapeutic use, Treatment Outcome, Anaphylaxis chemically induced, Antibodies, Monoclonal adverse effects, Antirheumatic Agents adverse effects, Arthritis, Juvenile complications, Arthritis, Juvenile drug therapy, Interleukin 1 Receptor Antagonist Protein adverse effects
- Abstract
We present the case of a 2-year-old boy with a history of necrotizing enterocolitis (NEC) with ileostomy diagnosed with systemic juvenile idiopathic arthritis (sJIA) at 10 months of age controlled on anti-interleukin-1 (anti-IL-1) therapy (anakinra). At 17 months of age, ileostomy reversal and bowel re-anastomosis was scheduled with anakinra discontinued 3 days prior to the surgery and steroids initiated in its place. Ten days postoperatively, anakinra was re-started for signs of sJIA flare. Three months later, he developed persistent peripheral eosinophilia and subsequent anaphylactic reaction 6 months postoperatively. The patient safely tolerated an alternative anti-IL-1 agent (canakinumab). Anaphylaxis to anakinra has not been previously reported in the pediatric literature. This case highlights an important issue in a pediatric patient with sJIA: safety of an alternate anti-IL-1 agent, following development of allergy to one initial agent.
- Published
- 2015
- Full Text
- View/download PDF
23. Pediatric antiphospholipid syndrome.
- Author
-
Aguiar CL, Soybilgic A, Avcin T, and Myones BL
- Subjects
- Age Factors, Antiphospholipid Syndrome etiology, Biomedical Research methods, Biomedical Research trends, Child, Humans, Infant, Newborn, Risk Factors, Antiphospholipid Syndrome diagnosis, Antiphospholipid Syndrome therapy
- Abstract
Antiphospholipid syndrome (APS) is a multisystem autoimmune condition characterized by vascular thromboses associated with persistently positive antiphospholipid antibodies. There is currently a paucity of data (incidence, prevalence, thrombosis risk, and effective treatment) in pediatric APS. The purpose of this report is to review the current literature on APS in children and neonates, identify the gaps in current knowledge, and suggest avenues for studies to fill those gaps.
- Published
- 2015
- Full Text
- View/download PDF
24. Structural and physicochemical characteristics of starch from sugar cane and sweet sorghum stalks.
- Author
-
Alves FV, Polesi LF, Aguiar CL, and Sarmento SB
- Subjects
- Crystallization, Gels chemistry, Thermodynamics, Water chemistry, X-Ray Diffraction, Saccharum chemistry, Sorghum chemistry, Starch chemistry
- Abstract
The starch present in sugar cane and sorghum juice has been considered a problem to the sugar industry. The objective of this work was to study the structural and physicochemical characteristics of the starch present in sugar cane and sweet sorghum. Sugar cane and sweet sorghum starches presented small granules (maximum 5.9 and 7.9 μm), A-type diffraction pattern, high degree of relative crystallinity (44.4 and 42.0%), and low amylose content (17.5 and 16.4%), respectively. Sugar cane starch presented more uniformity in granule shape and size, more homogeneity in amylose chain length, higher number of long lateral chains of amylopectin, and higher susceptibility to enzymatic digestion. Besides being in higher amount in the juice, sweet sorghum starch presented lower values for thermal properties of gelatinization, as well as higher swelling factor, which can cause more problems during processing. Additional studies are needed to evaluate the variety and maturity influence on these properties., (Copyright © 2014 Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
25. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.
- Author
-
Erkan D, Aguiar CL, Andrade D, Cohen H, Cuadrado MJ, Danowski A, Levy RA, Ortel TL, Rahman A, Salmon JE, Tektonidou MG, Willis R, and Lockshin MD
- Subjects
- Antibodies, Antiphospholipid therapeutic use, Anticoagulants therapeutic use, Antiphospholipid Syndrome complications, Factor Xa immunology, Humans, Hydroxychloroquine therapeutic use, Thrombosis drug therapy, Thrombosis etiology, Thrombosis prevention & control, Antibodies, Antiphospholipid immunology, Antiphospholipid Syndrome drug therapy, Antiphospholipid Syndrome immunology
- Abstract
Antiphospholipid Syndrome (APS) is characterized by vascular thrombosis and/or pregnancy morbidity occurring in patients with persistent antiphospholipid antibodies (aPL). The primary objective of the APS Treatment Trends Task Force, created as part of the 14th International Congress on aPL, was to systematically review the potential future treatment strategies for aPL-positive patients. The task force chose as future clinical research directions: a) determining the necessity for controlled clinical trials in venous thromboembolism with the new oral direct thrombin or anti-factor Xa inhibitors pending the results of the ongoing rivaroxaban in APS (RAPS) trial, and designing controlled clinical trials in other forms of thrombotic APS; b) systematically analyzing the literature as well as aPL/APS registries, and creating specific registries for non-warfarin/heparin anticoagulants; c) increasing recruitment for an ongoing primary thrombosis prevention trial, and designing secondary thrombosis and pregnancy morbidity prevention trials with hydroxychloroquine; d) determining surrogate markers to select patients for statin trials; e) designing controlled studies with rituximab and other anti-B-cell agents; f) designing mechanistic and clinical studies with eculizumab and other complement inhibitors; and g) chemically modifying peptide therapy to improve the half-life and minimize immunogenicity. The report also includes recommendations for clinicians who consider using these agents in difficult-to-manage aPL-positive patients., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
26. Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease.
- Author
-
Aguiar CL and Erkan D
- Abstract
Antiphospholipid syndrome (APS) is a multisystem autoimmune condition characterized by vascular thromboses and/or pregnancy loss associated with persistently positive antiphospholipid antibodies (aPL). Catastrophic APS (CAPS) is the most severe form of APS with multiple organ involvement developing over a short period of time, usually associated with microthrombosis. 'Definite' and 'probable' CAPS have been defined based on the preliminary classification criteria; however, in a real-world setting, aPL-positive patients with multiple organ thromboses and/or thrombotic microangiopathies exist who do not fulfill these criteria. Previous APS diagnosis and/or persistent clinically significant aPL positivity is of great importance for the CAPS diagnosis; however, almost half of the patients who develop CAPS do not have a history of aPL positivity. The purpose of this paper is to summarize the diagnostic challenges and the recently updated diagnostic algorithms for CAPS providing a 'step-by-step' approach for clinicians (and researchers) in the assessment of patients with multiple organ thromboses.
- Published
- 2013
- Full Text
- View/download PDF
27. Takayasu arteritis presenting in the context of active tuberculosis: a pediatric case.
- Author
-
Walters HM, Aguiar CL, Macdermott EJ, Adams A, Barinstein L, Dayton JD, Salvatore C, Thimmappa N, and Lehman TJ
- Subjects
- Adolescent, Adrenal Cortex Hormones therapeutic use, Antibodies, Monoclonal, Murine-Derived therapeutic use, Antitubercular Agents therapeutic use, Comorbidity, Drug Therapy, Combination, Female, Humans, Methotrexate therapeutic use, Rituximab, Takayasu Arteritis drug therapy, Treatment Outcome, Tuberculosis drug therapy, Mycobacterium tuberculosis, Takayasu Arteritis diagnosis, Takayasu Arteritis epidemiology, Tuberculosis diagnosis, Tuberculosis epidemiology
- Abstract
Takayasu arteritis (TA) is a large-vessel vasculitis, most commonly presenting in young adults and more rarely in pediatric patients. An apparent association between TA and Mycobacterium tuberculosis has been noted previously, although this potential relationship is not yet understood. We present the case of a 16-year-old Haitian girl diagnosed with TA, originally presenting in the context of active tuberculosis. Our patient has been treated with antituberculosis therapy, corticosteroids, methotrexate, and rituximab to control her continued active vasculitis. With this case report, we seek to promote further exploration of the apparent association between TA and tuberculosis, as further clarification of the nature of this relationship may lead to the development of more targeted therapies and better outcomes for TA patients.
- Published
- 2013
- Full Text
- View/download PDF
28. Changes in isoflavone profiles of soybean treated with gamma irradiation.
- Author
-
Aguiar CL, Baptista AS, Walder JM, Tsai SM, Carrão-Panizzi MC, and Kitajima EW
- Subjects
- Chromatography, High Pressure Liquid, Diet, Flour, Humans, Seeds chemistry, Seeds radiation effects, Soy Foods analysis, Glycine max chemistry, Food Handling methods, Gamma Rays, Genistein analysis, Isoflavones analysis, Soy Foods radiation effects, Glycine max radiation effects
- Abstract
Soybean is an important Brazilian agricultural commodity that contains a high concentration of isoflavones. Many studies showed that isoflavones are active in the prevention of many human diseases. However, the correct processing techniques used to prepare the soy foodstuffs are important to maintain the active forms. The objective of this study was to evaluate the effect of gamma irradiation on the isoflavone contents of the defatted soybean flour when compared with soybean molasses, a derivative from the soybean food production. After extracting phenolic compounds with methanol aqueous solution (80%), isoflavones were detected by reverse-phase high-performance liquid chromatography/diode-array detector. The radiation doses of 2 and 5 kGy presented a small effect on the isoflavones content of defatted soy flour. Samples irradiated at 50 kGy showed lower isoflavone contents. The observed reduction in the concentration of isoflavones-daidzein, glycitein and genistein-induced by gamma radiation in soy molasses was not significant in defatted soy flour, thus suggesting that isoflavones in defatted soy flour were not eliminated by gamma radiation at rates up to 50 kGy.
- Published
- 2009
- Full Text
- View/download PDF
29. Analysis of isoflavonoids from leguminous plant extracts by RPHPLC/DAD and electrospray ionization mass spectrometry.
- Author
-
Aguiar CL, Baptista AS, Alencar SM, Haddad R, and Eberlin MN
- Subjects
- Chromatography, High Pressure Liquid methods, Food Analysis methods, Genistein analysis, Humans, Spectrometry, Mass, Electrospray Ionization methods, Fabaceae chemistry, Isoflavones analysis
- Abstract
Traditionally, food is associated with energetic and nutritious characteristics such as sources of carbohydrates, proteins and lipids. Recently, however, foods with bioactive substances such as isoflavones have received great attention. The objective of this study was therefore to evaluate the presence of the isoflavones daidzein, glycitein, genistein and their conjugated forms in grains and leaves of several leguminous plants utilized largely in Brazilian cuisine. Grains used in Peruvian cuisine were also analyzed. After extracting phenolic compounds with methanol (80%), isoflavones as detected by reversed-phase high-performance liquid chromatography/ diode-array detector were only found in chickpeas and soybean. Chickpea extracts showed only the isoflavone genistein at 31 microg/g defatted flour. Detection of these isoflavones was confirmed by electrospray ionization mass and tandem mass spectrometric experiments. For soybean, a distinct distribution of isoflavones was found in hypocotyls and cotyledon. The highest concentration of isoflavones found was approximately 5.9 mg/g for hypocotyls, whereas the total concentration of isoflavone was around 0.4 mg/g for the cotyledons (dry matter). These results indicate that isoflavone concentrations vary within the different tissues of the leguminous species tested.
- Published
- 2007
- Full Text
- View/download PDF
30. [Historical and clinical review about Asperger syndrome].
- Author
-
Ortiz VK, Aguiar CL, and D'Antino ME
- Subjects
- Asperger Syndrome physiopathology, Humans, Interpersonal Relations, Social Adjustment, Asperger Syndrome psychology
- Published
- 2004
- Full Text
- View/download PDF
31. Chemical constituents in Baccharis dracunculifolia as the main botanical origin of southeastern Brazilian propolis.
- Author
-
Park YK, Paredes-Guzman JF, Aguiar CL, Alencar SM, and Fujiwara FY
- Subjects
- Animals, Anti-Infective Agents analysis, Bees, Brazil, Chromatography, High Pressure Liquid, Flavonoids analysis, Phenols analysis, Plant Leaves chemistry, Baccharis chemistry, Propolis analysis
- Abstract
Previously, it was reported that one group of propolis (Group 12) was identified in southeastern Brazil, and the botanical origin of the propolis was Baccharis dracunculifolia resinous exudates. It was also observed that honeybee (Africanized Apis mellifera) mainly visited the leaf buds or unexpanded leaves of B. dracunculifolia but rarely expanded leaves. B. dracunculifolia is dioecious with male and female inflorescences, and RPHPLC of the ethanolic extracts of the respective male and female bud resinous exudates showed the same profiles. RPHPLC profiles of propolis G12 leaf buds and unexpanded and expanded leaves of B. dracunculifolia showed similarity, but unexpanded leaves quantitatively decreased in chemical constituents as compared with leaf buds. In the case of expanded leaves, all chemical constituents were severely decreased or disappeared. Artepillin C (3,5-diprenyl-4-hydroxycinnamic acid) was also identified in both propolis and resinous exudates, and both ethanolic extracts contained the highest concentrations of this compound as compared with the rest of the chemical constituents.
- Published
- 2004
- Full Text
- View/download PDF
32. Botanical origin and chemical composition of Brazilian propolis.
- Author
-
Park YK, Alencar SM, and Aguiar CL
- Subjects
- Animals, Bees, Brazil, Chemical Phenomena, Chemistry, Physical, Chromatography, High Pressure Liquid, Gas Chromatography-Mass Spectrometry, Plant Leaves chemistry, Plant Structures chemistry, Propolis analysis, Resins, Plant analysis, Trees, Propolis chemistry
- Abstract
Brazilian propolis has been classified into 12 groups based on physicochemical characteristics: five in the southern Brazil group (group 3), one in the southeastern Brazil group (group 12), and six in the northeastern Brazil group (group 6). The plant origins of these groups were investigated using reversed-phase high-performance thin-layer chromatography (RPHPTLC), reversed-phase high-performance liquid chromatography (RPHPLC), and gas chromatography-mass spectrometry (GC-MS). It was concluded that the origins of propolis group 3, group 6, and group 12 are resins of the poplar tree, Hyptis divaricata, and Baccharis dracunculifolia, respectively.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.